Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Other Non Operating Income: 2009-2023

Historic Other Non Operating Income for BIO-TECHNE (TECH) over the last 13 years, with Jun 2023 value amounting to -$3.5 million.

  • BIO-TECHNE's Other Non Operating Income fell 544.97% to -$3.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $47.5 million, marking a year-over-year increase of 210.35%. This contributed to the annual value of $831,000 for FY2025, which is 109.68% up from last year.
  • Latest data reveals that BIO-TECHNE reported Other Non Operating Income of -$3.5 million as of Q2 2023, which was down 1,037.04% from $378,000 recorded in Q1 2023.
  • In the past 5 years, BIO-TECHNE's Other Non Operating Income registered a high of $118.0 million during Q4 2019, and its lowest value of -$58.3 million during Q2 2021.
  • In the last 3 years, BIO-TECHNE's Other Non Operating Income had a median value of $152,000 in 2022 and averaged -$1.6 million.
  • Over the last 5 years, BIO-TECHNE's Other Non Operating Income had its largest YoY gain of 2,005.59% in 2019, and its largest YoY loss of 25,355.00% in 2019.
  • Over the past 5 years, BIO-TECHNE's Other Non Operating Income (Quarterly) stood at $118.0 million in 2019, then plummeted by 92.47% to $8.9 million in 2020, then surged by 198.29% to $26.5 million in 2021, then plummeted by 100.28% to -$74,000 in 2022, then tumbled by 544.97% to -$3.5 million in 2023.
  • Its last three reported values are -$3.5 million in Q2 2023, $378,000 for Q1 2023, and -$74,000 during Q4 2022.